NWQ Investment Management Company LLC lessened its holdings in MedEquities Realty Trust Inc. (NYSE:MRT) by 6.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 666,490 shares of the financial services provider’s stock after selling 46,922 shares during the period. NWQ Investment Management Company LLC owned about 2.10% of MedEquities Realty Trust worth $7,831,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. raised its position in shares of MedEquities Realty Trust by 372.8% during the first quarter. Schwab Charles Investment Management Inc. now owns 320,531 shares of the financial services provider’s stock worth $3,594,000 after purchasing an additional 252,739 shares during the period. Boston Partners raised its position in MedEquities Realty Trust by 18.5% in the 2nd quarter. Boston Partners now owns 1,423,929 shares of the financial services provider’s stock valued at $17,970,000 after buying an additional 221,911 shares during the last quarter. Russell Investments Group Ltd. raised its position in MedEquities Realty Trust by 43.0% in the 2nd quarter. Russell Investments Group Ltd. now owns 642,623 shares of the financial services provider’s stock valued at $8,112,000 after buying an additional 193,182 shares during the last quarter. American Century Companies Inc. raised its position in MedEquities Realty Trust by 11.2% in the 3rd quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock valued at $20,283,000 after buying an additional 174,261 shares during the last quarter. Finally, State Street Corp raised its position in MedEquities Realty Trust by 41.7% in the 2nd quarter. State Street Corp now owns 529,702 shares of the financial services provider’s stock valued at $6,684,000 after buying an additional 155,934 shares during the last quarter. Institutional investors own 93.19% of the company’s stock.
In other MedEquities Realty Trust news, CEO John W. Mcroberts purchased 18,000 shares of the firm’s stock in a transaction dated Friday, November 17th. The stock was purchased at an average price of $10.74 per share, for a total transaction of $193,320.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Randy L. Churchey purchased 5,300 shares of the firm’s stock in a transaction dated Monday, November 20th. The stock was acquired at an average price of $10.87 per share, with a total value of $57,611.00. Following the purchase, the director now directly owns 46,776 shares of the company’s stock, valued at $508,455.12. The disclosure for this purchase can be found here. Insiders bought 23,600 shares of company stock valued at $254,129 in the last 90 days. Company insiders own 2.50% of the company’s stock.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 29th. Stockholders of record on Wednesday, November 15th were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 7.71%. The ex-dividend date of this dividend was Tuesday, November 14th. MedEquities Realty Trust’s dividend payout ratio is currently 210.01%.
A number of brokerages have issued reports on MRT. B. Riley restated a “buy” rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 1st. Capital One Financial initiated coverage on MedEquities Realty Trust in a report on Monday, October 23rd. They set an “equal weight” rating and a $13.00 price objective on the stock. KeyCorp set a $13.00 price objective on MedEquities Realty Trust and gave the stock a “buy” rating in a report on Sunday, October 29th. Cantor Fitzgerald initiated coverage on MedEquities Realty Trust in a report on Thursday, August 31st. They set an “overweight” rating and a $14.00 price objective on the stock. Finally, ValuEngine raised MedEquities Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, December 1st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $12.83.
TRADEMARK VIOLATION WARNING: This story was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://sportsperspectives.com/2017/12/08/medequities-realty-trust-inc-mrt-holdings-cut-by-nwq-investment-management-company-llc.html.
MedEquities Realty Trust Profile
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.